⚠ Evidence warning: Clinical trials or other evidence do not support the claims that high-dose vitamin C treats cancer by itself and treats sepsis. This page keeps it as a report of what people, websites or other media say.

Vitamin C — Benefits Deep Dive

Acerola cherries, among the richest vitamin C fruits
Acerola cherries, among the richest vitamin C fruits

Vitamin C produces clinically meaningful effects across an unusually wide range of conditions because four distinct biochemical mechanisms operate simultaneously inside every cell: water-soluble antioxidant defense (regenerating vitamin E, glutathione, and tetrahydrobiopterin), cofactor activity for at least 15 mononuclear iron and copper hydroxylases (collagen synthesis, neurotransmitter synthesis, carnitine production, peptide hormone amidation, HIF-1α degradation, TET-mediated DNA demethylation), immune-cell concentration at 50–100× plasma levels (neutrophils, lymphocytes), and — at intravenous (IV) pharmacological doses only — selective pro-oxidant hydrogen-peroxide generation that targets catalase-deficient cancer cells. Each benefit page below explores one specific therapeutic application in clinical-trial depth. Larger trials set limits on these effects, listed under What the Larger Trials Found.

Deep-Dive Articles

🛡️

Immune Function — Colds, Pneumonia, Sepsis

The Hemilä Cochrane reviews that quietly reshaped the clinical picture: regular Vitamin C does not prevent colds in normal adults, but cuts duration 8–14% and cuts incidence by 50% in athletes, soldiers, and people exposed to short bouts of severe physical or cold stress. Deep dive into the neutrophil chemotaxis / respiratory-burst mechanism, the Marik 2017 sepsis cocktail, the CITRIS-ALI trial, and the 1–2 g/day regular-use vs 6–8 g/day treatment dose split. The Cochrane review saw no consistent effect when vitamin C was started at the onset of a cold; the 6–8 g figure comes from two controlled dose-response trials.

Read the deep dive →
🩹

Collagen Synthesis, Wound Healing & Skin

Why scurvy is fundamentally a collagen disease — prolyl and lysyl hydroxylase are iron-dependent enzymes that cannot function without ascorbate. The full mechanism, the dosing for post-surgical recovery (500–2,000 mg/day), the Shaw 2017 gelatin + Vitamin C tendon-loading protocol, topical L-ascorbic acid (10–20% at pH 2.5–3.5) for photoaging, and the Vitamin C + Vitamin E pairing for skin.

Read the deep dive →
💉

Intravenous High-Dose Vitamin C & Cancer

An integrative-clinic protocol (50–100 g intravenous 1–2× weekly). Pharmacological vs physiological doses: plasma >1 mM is achievable only intravenously, not orally. The Padayatty U.S. National Institutes of Health (NIH) papers establishing the pro-oxidant H2O2 mechanism selectively toxic to catalase-deficient cancer cells. From Hoffer and Pauling through the Levine U.S. National Institutes of Health rehabilitation to the modern University of Kansas integrative oncology trials. Glucose-6-phosphate dehydrogenase (G6PD) screening, what the evidence shows, what it doesn't.

Read the deep dive →
🩸

Iron Absorption & Anemia

Ascorbate reduces Fe³+ to Fe²+ in the duodenum, the form the DMT1 transporter can absorb. Single-meal studies report 2–6× increased non-heme iron uptake when 75–100 mg is taken with a meal; a study of whole diets found a far smaller boost, and a 440-person trial saw no extra recovery when vitamin C was added to iron pills. Clinical application in iron-deficiency anemia, plant-based diets, and women with heavy menstrual bleeding. Dosing-timing rules, the copper-depletion caution at chronic high doses, and why vitamin C's boost to iron absorption is the concern in iron overload (hemochromatosis).

Read the deep dive →
🩸

Vitamin C in Blood Disorders: The EVITA Trial

A randomised, placebo-controlled trial of oral vitamin C in precancerous and lower-risk blood disorders: no difference on its main measure, and a survival signal it was not designed to test.

Read the deep dive →

Back to Table of Contents

🍊 Interactive Visualization Vitamin C, Collagen & Why Sailors Fell Apart Zip three protein chains into the strongest rope in biology — then take the vitamin C away and watch the helix unravel, and old healed scars split back open. Launch →

Table of Contents

  1. Deep-Dive Articles
  2. Why Vitamin C Produces Effects Across So Many Conditions
  3. What the Larger Trials Found
  4. Research Papers: Immune Function
  5. Research Papers: Collagen, Wound Healing & Skin
  6. Research Papers: Intravenous High-Dose & Cancer
  7. Research Papers: Iron Absorption & Anemia
  8. Research Papers: Cross-Cutting (Forms, Pharmacokinetics, Safety)
  9. External Authoritative Resources
  10. Connections
  11. Featured Videos

Why Vitamin C Produces Effects Across So Many Conditions

Few molecules in human biology touch as many systems as ascorbate. The reason is that Vitamin C is not "an antioxidant" with one mechanism — it is at minimum four distinct biochemical entities operating in parallel, and each maps to a different category of clinical benefit.

  1. Mononuclear iron / 2-oxoglutarate-dependent dioxygenase cofactor. At least 15 enzymes in human biochemistry require Vitamin C to keep their iron (or copper) center in the active reduced state. The most important: prolyl-4-hydroxylase and lysyl hydroxylase (collagen synthesis), dopamine-β-hydroxylase (norepinephrine synthesis), γ-butyrobetaine hydroxylase (carnitine biosynthesis), peptidylglycine α-amidating monooxygenase (peptide hormone activation), HIF-prolyl hydroxylase (HIF-1α degradation), and the TET1/2/3 + JmjC enzyme families (DNA and histone demethylation). When ascorbate is depleted these enzymes silently lose activity long before frank scurvy appears.
  2. The universal water-soluble antioxidant. Direct scavenger of superoxide, hydroxyl radical, peroxyl radicals, peroxynitrite, and singlet oxygen. The first electron donor in the antioxidant network — the molecule that regenerates α-tocopheroxyl radical back to active vitamin E at the lipid-water interface, that recycles oxidized glutathione, and that keeps tetrahydrobiopterin (BH4) reduced so nitric oxide synthase and tryptophan hydroxylase keep working.
  3. Immune-cell concentration mechanism. Neutrophils and lymphocytes actively transport ascorbate via the SVCT2 transporter to concentrations 50–100× higher than plasma. This concentration drives the neutrophil chemotaxis, respiratory burst, natural killer (NK) cell cytotoxicity, T-cell proliferation, and antibody production findings — effects that disappear in even mild deficiency.
  4. Pharmacological pro-oxidant (intravenous only). At plasma concentrations above 1 mM — achievable only by intravenous infusion, never by oral dosing — ascorbate auto-oxidizes in the extracellular space to generate hydrogen peroxide. Normal cells with intact catalase activity tolerate this; many cancer cells with low catalase do not. This is the high-dose intravenous protocol mechanism — a different drug, in effect, from the same molecule taken orally.

Additional clinically important effects include reduction of dietary Fe³+ to absorbable Fe²+ in the duodenum, mast-cell stabilization and histamine degradation, nitrosamine inhibition in the stomach, and TET-mediated reactivation of silenced tumor suppressor genes. The combination is why Vitamin C shows up across infectious disease, wound healing, dermatology, hematology, integrative oncology, cardiology, allergy, and longevity research with a credible mechanistic story in each case. A mechanism is not the same as a result in people, and the section below lists what the larger trials found.

Back to Table of Contents

What the Larger Trials Found

The mechanisms above do not always carry through to results in people. These are the largest trials and reviews, and where each one drew its limit.

Back to Table of Contents

Research Papers: Immune Function

  1. Hemilä H, Chalker E (2013). Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews. — PubMed PMID: 23440782
  2. Hemilä H (1996). Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int J Sports Med. — PubMed PMID: 8858411
  3. Marik PE et al. (2017). Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. — PubMed PMID: 27940189
  4. Fowler AA et al. (2019). Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. — PubMed PMID: 31573637
  5. Carr AC, Maggini S (2017). Vitamin C and immune function. Nutrients. — PubMed PMID: 29099763
  6. Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F (1996). Vitamin C for the treatment of recurrent furunculosis in patients with impaired neutrophil functions. J Infect Dis. — PubMed PMID: 8648230
  7. Hunt C et al. (1994). The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res. — PubMed PMID: 7814237
  8. Sasazuki S et al. (2006). Effect of vitamin C on common cold: randomized controlled trial. Eur J Clin Nutr. — PubMed PMID: 16118650
  9. Anderson TW et al. (1972). Vitamin C and the common cold: a double-blind trial. CMAJ. — PubMed PMID: 5057006
  10. Hemilä H, de Man AME (2020). Vitamin C and COVID-19. Frontiers in Medicine. — PubMed PMID: 33537320
  11. Fowler AA et al. (2017). Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndrome. World J Crit Care Med. — PubMed PMID: 28224112
  12. Bharara A et al. (2016). Intravenous vitamin C administered as adjunctive therapy for recurrent acute respiratory distress syndrome. Case Rep Crit Care. — PubMed PMID: 27891260
  13. Wintergerst ES, Maggini S, Hornig DH (2006). Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. — PubMed PMID: 16373990
  14. Hemilä H (2017). Vitamin C and infections. Nutrients. — PubMed PMID: 28353648
  15. Hemilä H, Chalker E (2023). Vitamin C reduces the severity of common colds: a meta-analysis. BMC Public Health. — PubMed PMID: 38082300
  16. Lamontagne F et al. (2022). Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. — PubMed PMID: 35704292
  17. LOVIT-COVID Investigators et al. (2023). Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA. — PubMed PMID: 37877585

Back to Table of Contents

Research Papers: Collagen, Wound Healing & Skin

  1. Pinnell SR (1985). Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J Biol Med. — PubMed PMID: 3008449
  2. Kivirikko KI, Myllylä R (1985). Post-translational processing of procollagens. Ann NY Acad Sci. — PubMed PMID: 3008623
  3. Shaw G et al. (2017). Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr. — PubMed PMID: 27852613
  4. Telang PS (2013). Vitamin C in dermatology. Indian Dermatol Online J. — PubMed PMID: 23741676
  5. Pullar JM, Carr AC, Vissers MCM (2017). The roles of vitamin C in skin health. Nutrients. — PubMed PMID: 28805671
  6. Mohammed BM et al. (2013). Vitamin C: a novel regulator of neutrophil extracellular trap formation. Nutrients. — PubMed PMID: 23939536
  7. Humbert PG et al. (2003). Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol. — PubMed PMID: 12823436
  8. Lin JY et al. (2003). UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol. — PubMed PMID: 12789176
  9. DePhillipo NN et al. (2018). Efficacy of vitamin C supplementation on collagen synthesis and oxidative stress after musculoskeletal injuries: a systematic review. Orthop J Sports Med. — PubMed PMID: 30386805

Back to Table of Contents

Research Papers: Intravenous High-Dose & Cancer

  1. Cameron E, Pauling L (1976). Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. PNAS. — PubMed PMID: 1068480
  2. Padayatty SJ et al. (2004). Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. — PubMed PMID: 15068981
  3. Chen Q et al. (2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. PNAS. — PubMed PMID: 16157892
  4. Chen Q et al. (2008). Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. PNAS. — PubMed PMID: 18678913
  5. Welsh JL et al. (2013). Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol. — PubMed PMID: 23381814
  6. Hoffer LJ et al. (2008). Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol. — PubMed PMID: 18544557
  7. Riordan HD et al. (2005). A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. PR Health Sci J. — PubMed PMID: 16570523
  8. Schoenfeld JD et al. (2017). O2⋅− and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. — PubMed PMID: 28810149
  9. Yun J et al. (2015). Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. — PubMed PMID: 26541605
  10. Polireddy K et al. (2017). High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: mechanisms and a phase I/IIa study. Sci Rep. — PubMed PMID: 29215048
  11. Padayatty SJ et al. (2010). Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS ONE. — PubMed PMID: 20628650
  12. Cieslak JA, Cullen JJ (2015). Treatment of pancreatic cancer with pharmacological ascorbate. Curr Pharm Biotechnol. — PubMed PMID: 26201606
  13. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM (1985). High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. — PubMed PMID: 3880867
  14. Bodeker KL et al. (2024). A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biol. — PubMed PMID: 39369582

Back to Table of Contents

Research Papers: Iron Absorption & Anemia

In plain words: studies that feed one meal to fasting people show vitamin C giving iron absorption a large boost. Cook and Reddy (2001) then measured whole diets in 12 people and found no significant difference in mean absorption across vitamin C intakes of 51–247 mg/day, calling the effect "far less pronounced" than in single meals. Li and colleagues (2020) gave 440 adults with iron-deficiency anemia a 100 mg iron tablet every 8 hours, with or without 200 mg of vitamin C. Hemoglobin rose 2.00 and 1.84 g/dL at 2 weeks, which met the trial's test for equivalence, and the authors wrote that on-demand vitamin C is "not essential" alongside oral iron.

  1. Hallberg L et al. (1989). The role of vitamin C in iron absorption. Int J Vitam Nutr Res Suppl. — PubMed PMID: 2507689
  2. Cook JD, Reddy MB (2001). Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr. — PubMed PMID: 11124756
  3. Lynch SR, Cook JD (1980). Interaction of vitamin C and iron. Ann NY Acad Sci. — PubMed PMID: 6940487
  4. Li N et al. (2020). The efficacy and safety of vitamin C for iron supplementation in adult patients with iron deficiency anemia: a randomized clinical trial. JAMA Netw Open. — PubMed PMID: 33136134
  5. Finkelstein JL et al. (2020). Anaemia and iron deficiency in pregnancy and adverse perinatal outcomes in Southern India. Eur J Clin Nutr. — PubMed PMID: 31296936
  6. Fishman SM, Christian P, West KP (2000). The role of vitamins in the prevention and control of anaemia. Public Health Nutr. — PubMed PMID: 10948381
  7. Finley EB, Cerklewski FL (1983). Influence of ascorbic acid supplementation on copper status in young adult men. Am J Clin Nutr. — PubMed PMID: 6837490
  8. Olivares M, Pizarro F (2001). Bioavailability of iron bis-glycinate chelate in water. Arch Latinoam Nutr. — PubMed PMID: 11688077
  9. Stoffel NU et al. (2020). Oral iron supplementation in iron-deficient women: how much and how often? Mol Aspects Med. — PubMed PMID: 32650997

Back to Table of Contents

Research Papers: Cross-Cutting (Forms, Pharmacokinetics, Safety)

  1. Levine M et al. (1996). Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. PNAS. — PubMed PMID: 8623000
  2. Davis JL et al. (2016). Liposomal-encapsulated ascorbic acid: influence on vitamin C bioavailability and capacity to protect against ischemia-reperfusion injury. Nutr Metab Insights. — PubMed PMID: 27375360
  3. Cathcart RF (1981). Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses. — PubMed PMID: 7321921
  4. Cimmino L et al. (2017). Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. — PubMed PMID: 28823558
  5. Agus DB, Vera JC, Golde DW (1999). Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res. — PubMed PMID: 10493506
  6. Hoffer LJ (2008). Vitamin therapy in schizophrenia. Isr J Psychiatry Relat Sci. — PubMed PMID: 18587164
  7. Carr AC, Rowe S (2020). Factors affecting vitamin C status and prevalence of deficiency: a global health perspective. Nutrients. — PubMed PMID: 32630245
  8. Padayatty SJ, Levine M (2016). Vitamin C: the known and the unknown and Goldilocks. Oral Dis. — PubMed PMID: 26808119
  9. Massey LK, Liebman M, Kynast-Gales SA (2005). Ascorbate increases human oxaluria and kidney stone risk. J Nutr. — PubMed PMID: 15987848
  10. Ferraro PM, Curhan GC, Gambaro G, Taylor EN (2016). Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones. Am J Kidney Dis. — PubMed PMID: 26463139
  11. Lykkesfeldt J, Tveden-Nyborg P (2019). The pharmacokinetics of vitamin C. Nutrients. — PubMed PMID: 31601028

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents